{
  "id": "f60fe1ecabe0c3a1",
  "title": "STAT+: Abridge CTO on Epic and what\u2019s after AI scribing",
  "description": "In this edition of STAT Health Tech: Q&#038;A with Abridge CTO, telehealth pushing multi-cancer detection tests, and Novo's lawsuit against Hims.",
  "content": "In this edition of STAT Health Tech: Q&#038;A with Abridge CTO, telehealth pushing multi-cancer detection tests, and Novo's lawsuit against Hims.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/10/abridge-cto-epic-whats-after-scribing-health-tech/?utm_campaign=rss",
  "published_at": "2026-02-10T19:18:50+00:00",
  "fetched_at": "2026-02-11T00:34:18.892628+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Abridge CTO on Epic and what\u2019s after AI scribing",
    "description": "In this edition of STAT Health Tech: Q&#038;A with Abridge CTO, telehealth pushing multi-cancer detection tests, and Novo's lawsuit against Hims.",
    "url": "https://www.statnews.com/2026/02/10/abridge-cto-epic-whats-after-scribing-health-tech/?utm_campaign=rss",
    "published": "2026-02-10T19:18:50+00:00",
    "source": "STAT"
  }
}